Novel molecular events in oral carcinogenesis via integrative approaches

Journal of Dental Research

Volumn 90, Issue 5, 2011, Pages 561-572

  Wu, R Q ^a   Zhao, X F ^a   Wang, Z Y ^a   Zhou, M ^a   Chen, Q M ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

molecular mechanism; omics; oral squamous cell carcinoma; proteomics; systems biology

Indexed keywords

SIGNAL PEPTIDE; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL; BLOOD; CANCER INVASION; CELL COMMUNICATION; CELL TRANSFORMATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGICAL TOLERANCE; METABOLISM; METHODOLOGY; MOUTH TUMOR; PATHOGENICITY; PHYSIOLOGY; REVIEW; SALIVA; SQUAMOUS CELL CARCINOMA; SYSTEMS BIOLOGY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNE TOLERANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; SALIVA; SYSTEMS BIOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 79955823353     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510383691     Document Type: Review

References (92)

1. Alevizos I., Mahadevappa M., Zhang X., Ohyama H., Kohno Y., Posner M., et al. (2001). Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20: 6196-6204. (Pubitemid 32964432)
2. Argon Y., Simen BB (1999). GRP94, an ER chaperone with protein and peptide binding properties. Semin Cell Dev Biol 10: 495-505. (Pubitemid 129513640)
3. Benelli R., Lorusso G., Albini A., Noonan DM (2006). Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 12: 3101-3115. (Pubitemid 44227572)
4. Bijian K., Mlynarek AM, Balys RL, Jie S., Xu Y., Hier MP, et al. (2009). Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J Proteome Res 8: 2173-2185.
5. Boehm U., Klamp T., Groot M., Howard JC (1997). Cellular responses to interferon-γ. Annu Rev Immunol 15: 749-795.
6. Chambers TJ (2000). Regulation of the differentiation and function of osteoclasts. J Pathol 192: 4-13.
7. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008). Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26: 612-619. (Pubitemid 351264356)
8. Chen C., Mendez E., Houck J., Fan W., Lohavanichbutr P., Doody D., et al. (2008). Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17: 2152-2162.
9. Chi LM, Lee CW, Chang KP, Hao SP, Lee HM, Liang Y., et al. (2009). Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics 8: 1453-1474.
10. Choi S., Myers JN (2008). Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87: 14-32 ; erratum in J Dent Res 87: 191, 2008.
11. Craven RA, Banks RE (2001). Laser capture microdissection and proteomics: possibilities and limitation. Proteomics 1: 1200-1204.
12. Deyama Y., Tei K., Yoshimura Y., Izumiyama Y., Takeyama S., Hatta M., et al. (2008). Oral squamous cell carcinomas stimulate osteoclast differentiation. Oncol Rep 20: 663-668.
13. Franzmann EJ, Reategui EP, Pedroso F., Pernas FG, Karakullukcu BM, Carraway KL, et al. (2007). Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16: 1348-1355. (Pubitemid 47076863)
14. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT (2002). Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24: 165-180. (Pubitemid 34111514)
15. Gourin CG, Xia ZS, Han Y., French AM, O'Rourke AK, Terris DJ, et al. (2006). Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132: 390-397.
16. Grottkau BE, Chen XR, Friedrich CC, Yang XM, Jing W., Wu Y., Cai XX, Liu YR, Huang YD, Lin YF, (2009). DAPT enhances the apoptosis of human tongue carcinoma cells Int J Oral Sci 1 (2). 81-89.
17. Grundmann O., Mitchell GC, Limesand KH (2009). Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res 88: 894-903.
18. Hajkova D., Rao KC, Miyagi M. (2006). pH dependency of the carboxyl oxygen exchange reaction catalyzed by lysyl endopeptidase and trypsin. J Proteome Res 5: 1667-1673. (Pubitemid 44036140)
19. Hanahan D., Weinberg RA (2000). The hallmarks of cancer. Cell 100: 57-70. (Pubitemid 30046295)
20. He QY, Chen J., Kung HF, Yuen AP, Chiu JF (2004). Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4: 271-278. (Pubitemid 38140892)
21. Hennessey PT, Westra WH, Califano JA (2009). Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res 88: 300-306.
22. Henson DE, Srivastava S., Kramer BS (1999). Molecular and genetic targets in early detection. Curr Opin Oncol 11: 419-425. (Pubitemid 29410889)
23. Herrmann PC, Liotta LA, Petricoin EF 3rd (2001). Cancer proteomics: the state of the art. Dis Markers 17: 49-57. (Pubitemid 32964836)
24. Hinestrosa MC, Dickersin K., Klein P., Mayer M., Noss K., Slamon D., et al. (2007). Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Nat Rev Cancer 7: 309-315. (Pubitemid 46480973)
25. Hiroi M., Mori K., Sekine K., Sakaeda Y., Shimada J., Ohmori Y. (2009). Mechanisms of resistance to interferon-gamma-mediated cell growth arrest in human oral squamous carcinoma cells J Biol Chem 284: 24869-24880.
26. Hood BL, Darfler MM, Guiel TG, Furusato B., Lucas DA, Ringeisen BR, et al. (2005). Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics 4: 1741-1753. (Pubitemid 41749267)
27. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J. (2006). Cancer: a systems biology disease. Biosystems 83: 81-90. (Pubitemid 43199809)
28. Hu S., Arellano M., Boontheung P., Wang J., Zhou H., Jiang J., et al. (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14: 6246-6252.
29. Huang X., Wei Y., Li L., Wen Y., Yang J., Liu B., et al. (2006). Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol 42: 26-31. (Pubitemid 41831518)
30. Ishikawa T., Nakashiro K., Hara S., Klosek SK, Li C., Shintani S., et al. (2006). CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma. Int J Oncol 28: 61-66.
31. Jacob RJ, Cramer R. (2006). PIGOK: linking protein identity to gene ontology and function. J Proteome Res 5: 3429-3432. (Pubitemid 44904334)
32. Jewett A., Head C., Cacalano NA (2006). Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 85: 1061-1073. (Pubitemid 44935523)
33. Jung DW, Che ZM, Kim J., Kim K., Kim KY, Williams D. (2009). Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer 127: 322-344.
34. Kayamori K., Sakamoto K., Nakashima T., Takayanagi H., Morita K., Omura K., et al. (2010). Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am J Pathol 176: 968-980.
35. Kitano H. (2002). Systems biology: a brief overview. Science 295: 1662-1664. (Pubitemid 34202893)
36. Klussmann JP, Weissenborn SJ, Wieland U., Dries V., Eckel HE, Pfister HJ, et al. (2003). Human papillomavirus-positive tonsillar carcinomas: a different tumor entity ? Med Microbiol Immunol 192: 129-132. (Pubitemid 37100655)
37. Koehn J., Krapfenbauer K., Huber S., Stein E., Sutter W., Watzinger F., et al. (2008). Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res 7: 3818-3829.
38. Laubenbacher R., Hower V., Jarrah A., Torti SV, Shulaev V., Mendes P., et al. (2009). A systems biology view of cancer. Biochim Biophys Acta 1796: 129-139.
39. Lee JI, Jin BH, Kim MA, Yoon HJ, Hong SP, Hong SD (2009). Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: 678-684.
40. Liu ET (2005). Systems biology, integrative biology, predictive biology. Cell 121: 505-506. (Pubitemid 40720003)
41. Lo WY, Lai CC, Hua CH, Tsai MH, Huang SY, Tsai CH, et al. (2007 a). S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 6: 2143-2151.
42. Lo WY, Tsai MH, Tsai Y., Hua CH, Tsai FJ, Huang SY, et al. (2007 b). Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 376: 101-107. (Pubitemid 44880973)
43. Lockwood WW, Chari R., Chi B., Lam WL (2006). Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet 14: 139-148. (Pubitemid 43135854)
44. Mantovani A. (2009). Cancer: inflaming metastasis. Nature 457: 36-37.
45. Melle C., Ernst G., Schimmel B., Bleul A., Koscielny S., Wiesner A., et al. (2004). A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res 64: 4099-4104. (Pubitemid 38802410)
46. Melle C., Bogumil R., Ernst G., Schimmel B., Bleul A., von Eggeling F. (2006). Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling. Proteomics 6: 2600-2608.
47. Melle C., Ernst G., Winkler R., Schimmel B., Klussmann JP, Wittekindt C., et al. (2009). Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics 9: 2193-2201.
48. Mendez E., Houck JR, Doody DR, Fan W., Lohavanichbutr P., Rue TC, et al. (2009). A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res 15: 1353-1361.
49. Miyagi M., Rao KC (2007). Proteolytic 18O-labeling strategies for quantitative proteomics. Mass Spectrom Rev 26: 121-136. (Pubitemid 46061256)
50. Mucke T., Holzle F., Wagenpfeil S., Wolff KD, Kesting M. (2010). The role of tumor invasion into the mandible of oral squamous cell carcinoma. J Cancer Res Clin Oncol [Epub ahead of print, March 31, 2010 ] (in press).
51. Mulligan JK, Day TA, Gillespie MB, Rosenzweig SA, Young MR (2009). Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions Hum Immunol 70: 375-382.
52. Nagaraj NS (2009). Evolving 'omics' technologies for diagnostics of head and neck cancer. Brief Funct Genomic Proteomic 8: 49-59.
53. Nagler R., Bahar G., Shpitzer T., Feinmesser R. (2006). Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin Cancer Res 12: 3979-3984. (Pubitemid 44078083)
54. Nazmul-Hossain AN, Patel KJ, Rhodus NL, Moser KL (2008). Microarrays: applications in dental research. Oral Dis 14: 25-29. (Pubitemid 350293985)
55. Neiva KG, Zhang Z., Miyazawa M., Warner KA, Karl E., Nör JE (2009). Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling Neoplasia 11: 583-593.
56. Nomura H., Uzawa K., Yamano Y., Fushimi K., Ishigami T., Kato Y., et al. (2007). Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. Br J Cancer 97: 792-801. (Pubitemid 47396293)
57. O'Donnell RK, Kupferman M., Wei SJ, Singhal S., Weber R., O'Malley B., et al. (2005). Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24: 1244-1251. (Pubitemid 40313925)
58. Ong SE, Mann M. (2006). A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 1: 2650-2660.
59. Ong SE, Blagoev B., Kratchmarova I., Kristensen DB, Steen H., Pandey A., et al. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
60. Pandruvada SN, Yuvaraj S., Liu X., Sundaram K., Shanmugarajan S., Ries WL, et al. (2010). Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. Int J Cancer 126: 2319-2329.
61. Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543. (Pubitemid 33586866)
62. Patel V., Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, et al. (2008). Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 14: 1002-1014. (Pubitemid 351302545)
63. Pepe MS, Etzioni R., Feng Z., Potter JD, Thompson ML, Thornquist M., et al. (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061. (Pubitemid 32717537)
64. Pestka S., Langer JA, Zoon KC, Samuel CE (1987). Interferons and their actions. Annu Rev Biochem 56: 727-777. (Pubitemid 17105465)
65. Ransohoff RM (2009). Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31: 711-721.
66. Reddy SV (2004). Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr 14: 255-270. (Pubitemid 40221056)
67. Rehman AO, Wang CY (2008). SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappaB. J Biol Chem 283: 19888-19894.
68. Rehman AO, Wang CY (2009). CXCL12/SDF-1α activates NF-δB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex Int J Oral Sci 1: 105-118.
69. Reimers N., Kasper HU, Weissenborn SJ, Stutzer H., Preuss SF, Hoffmann TK, et al. (2007). Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120: 1731-1738. (Pubitemid 46399359)
70. Rubin JB (2009). Chemokine signaling in cancer: one hump or two? Semin Cancer Biol 19: 116-122.
71. Sawyers CL (2008). The cancer biomarker problem. Nature 452: 548-552. (Pubitemid 351483368)
72. Schadt EE, Zhang B., Zhu J. (2009). Advances in systems biology are enhancing our understanding of disease and moving us closer to novel disease treatments Genetica 136: 259-269.
73. Shiio Y., Aebersold R. (2006). Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat Protoc 1: 139-145.
74. Shinriki S., Jono H., Ota K., Ueda M., Kudo M., Ota T., et al. (2009). Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Clin Cancer Res 15: 5426-5434.
75. Sidransky D., Irizarry R., Califano JA, Li X., Ren H., Benoit N., et al. (2003). Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects. J Natl Cancer Inst 95: 1711-1717. (Pubitemid 37521219)
76. Soltys SG, Le QT, Shi G., Tibshirani R., Giaccia AJ, Koong AC (2004). The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 10: 4806-4812. (Pubitemid 38955534)
77. Suzuki E., Imoto I., Pimkhaokham A., Nakagawa T., Kamata N., Kozaki KI, et al. (2007). PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene 26: 7921-7932. (Pubitemid 350261784)
78. Tang CH, Chuang JY, Fong YC, Maa MC, Way TD, Hung CH (2008). Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis 29: 1483-1492.
79. Tang DG, Conti CJ (2004). Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update. Semin Thromb Hemost 30: 109-117. (Pubitemid 38457305)
80. Tavassoli M., Brunel N., Maher R., Johnson NW, Soussi T. (1998). p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer 78: 390-391. (Pubitemid 28445381)
81. Teicher BA, Fricker SP (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer Clin Cancer Res 16: 2927-2931.
82. Turhani D., Krapfenbauer K., Thurnher D., Langen H., Fountoulakis M. (2006). Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27: 1417-1423.
83. Unwin RD, Sternberg DW, Lu Y., Pierce A., Gilliland DG, Whetton AD (2005). Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL. J Biol Chem 280: 6316-6326. (Pubitemid 40341178)
84. Wang Z., Jiang L., Huang C., Li Z., Chen L., Gou L., et al. (2008). Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 7: 1639-1650.
85. Wang Z., Feng X., Liu X., Jiang L., Zeng X., Ji N., et al. (2009a). Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis. BMC Genomics 10: 383.
86. Wang Z., Zhang B., Jiang L., Zeng X., Chen Y., Feng X., et al. (2009b). RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J Cancer 45: 490-496.
87. Weng LP, Wu CC, Hsu BL, Chi LM, Liang Y., Tseng CP, et al. (2008). Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J Proteome Res 7: 3765-3775.
88. Xie H., Onsongo G., Popko J., de Jong EP, Cao J., Carlis JV, et al. (2008). Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 7: 486-498. (Pubitemid 351472459)
89. Yamaguchi M. (2009). RANK/RANKL/OPG during orthodontic tooth movement. Orthod Craniofac Res 12: 113-119.
90. Yuvaraj S., Griffin AC, Sundaram K., Kirkwood KL, Norris JS, Reddy SV (2009). A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells Mol Cancer Res 7: 1399-1407.
91. Zang L., Palmer Toy D., Hancock WS, Sgroi DC, Karger BL (2004). Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res 3: 604-612. (Pubitemid 39207366)
92. Zhao D., Xu QG, Chen XM, Fan MW (2009). Human papillomavirus as an independent predictor in oral squamous cell cancer Int J Oral Sci 1: 119-125.